Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001628280-18-001719
Filing Date
2018-02-15
Accepted
2018-02-14 18:43:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G agi-2017anipharmaceuticals.htm SC 13G 92310
  Complete submission text file 0001628280-18-001719.txt   93947
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Subject) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60689 | Film No.: 18615365
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1633 BROADWAY NEW YORK NY 10019
Business Address 1633 BROADWAY NEW YORK NY 10019 212-739-3000
Allianz Global Investors U.S. Holdings LLC (Filed by) CIK: 0001567940 (see all company filings)

EIN.: 330977088 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G